Home / Industries / Pharmaceuticals
WHO-GMP capex, export finance and working capital for formulations, API and nutraceutical companies.
Pharma balance sheets carry regulatory capex that generates no revenue until approvals land: WHO-GMP upgrades, stability studies, and export registrations — followed by 90–150 day receivables from institutional and export buyers.
LOANYARD CAPITAL funds compliance and capacity capex, structures export packing credit and bill discounting for regulated-market shipments, and arranges working capital that respects long pharma cash cycles.
We offer comprehensive funding options tailored to the specific needs of the Pharmaceuticals sector. From working capital to long-term growth financing, explore our specialized solutions below.
Case Study
₹19 Crore — EU-GMP upgrade + export limits
A formulations maker needed an EU-GMP line upgrade to convert three pending European contracts, while existing limits were fully drawn against African-market receivables.
We funded the ₹8 Cr upgrade as a term loan with 15-month moratorium matching the approval timeline, and enhanced export limits to ₹11 Cr with post-shipment discounting of ECGC-covered receivables.
Collateral-free and secured business loans from ₹10 Lakh to ₹50 Crore, structured by corporate finance specialists and placed with the right lender from our network of leading financial institutions.
From CGTMSE-backed collateral-free loans to structured working capital, we help micro, small and medium enterprises access bank-grade funding on terms usually reserved for large corporates.
Cash credit, overdrafts, bill discounting and structured working capital limits — designed around your operating cycle and placed with lenders who understand your industry.
Government-guaranteed funding for MSMEs — no property, no third-party guarantee.
New or used, indigenous or imported — machinery and equipment finance up to ₹50 Crore with up to 90% funding, structured around your production economics.
For mid-market and large corporates raising ₹25 Crore to ₹1,000 Crore — we run competitive, multi-lender processes across banks, NBFCs, AIFs and debt funds to deliver the right capital at the right price.